PXMD Insider Trading Activity and SEC Form 4 Filings
PXMD insider trading summary
No open-market insider purchases or sales of PaxMedica, Inc. (PXMD) have been reported on SEC Form 4 in the past 12 months.
Latest PXMD insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 29, 2024 | Zachary Rome | Director | Sell | $389 (811 @ $0.48) |
| Jan 29, 2024 | John F Coelho | Director | Sell | $13 (27 @ $0.48) |
| Jan 29, 2024 | Howard J. Weisman | Chief Executive Officer | Sell | $175 (372 @ $0.47) |
| Jan 29, 2024 | Karen LaRochelle | Director | Sell | $37 (78 @ $0.48) |
| Nov 27, 2023 | Zachary Rome | Director | Sell | $370 (359 @ $1.03) |
| Nov 27, 2023 | Michael Derby | 10% Owner | Sell | $190 (185 @ $1.03) |
| Nov 27, 2023 | Howard J. Weisman | Chairman and CEO | Sell | $166 (162 @ $1.03) |
| Nov 27, 2023 | John F Coelho | Director | Sell | $12 (12 @ $1.02) |
| Nov 27, 2023 | Karen LaRochelle | Director | Sell | $36 (35 @ $1.03) |
| Oct 27, 2023 | John F Coelho | Director | Sell | $108 (570 @ $0.19) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.